高橋 賢

Tag: heart disease

Video released: model for ischemic heart disease with human iPS cardiomyocytes

Summary Dr. Ken Takahashi of Okayama University published a video article about the model of ischemic heart disease using human iPS heart cells. The method makes it easier than before to create a cardiac ischemia model. The use of this model will lead to the development of drugs for ischemic heart disease and the elucidation…
Read more

Research Report 2019: Elucidation of the mechanism of arrhythmia during myocardial infarction by heart-on-a-chip

The principal investigator, Ken Takahashi, traveled to Boston, USA from the end of July 2018, and began research at the Wyss Institute at Harvard University. His original plan was to complete the joint research at the end of July 2019 and return to Japan. Related: Joining Harvard Medical School However, Takahashi joined the “Blood-Brain Barrier…
Read more

Outstanding Research Award in IC-LYMS2019 in Taipei

Ken Takahashi received the Outstanding Research Award in 2019 International Conference for Leading and Young Medical Scientists (IC-LYMS 2019) in Taipei, Taiwan, which was organized by Asia Pacific Society for Biology and Medical Sciences. The purpose of the conference was to provide a platform for the exchange and networking between top scientists, emerging young researchers,…
Read more

Lab member Chen Wang received the 1st Poster prize in IC-LYMS2019

Dr. Chen Wang, PhD student in Takahashi lab, won the 1st prize in poster presentation in 2019 International Conference for Leading and Young Medical Scientists (IC-LYMS 2019) held by Asia Pacific Society for Biology and Medical Sciences in Taipei. She gave a poster presentation entitled “Roles of the TRPM4 channel in mitochondrial function, ROS generation,…
Read more

Heart attack modeled with human stem cells

Toward the development of individual model of ischemic heart disease Heart attack caused by ischemia is a major medical problem that threatens our healthy life. Researchers at Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences developed a model of myocardial infarction using cardiomyocytes differentiated from human induced pluripotent stem cells. The journal Biochemical and…
Read more

en_USEnglish
jaJapanese en_USEnglish